TGA Approval

ZIRABEV bevacizumab 100 mg/ 4 mL concentrated solution for injection vial (309320)

ARTG ID

309320

ARTG Name

ZIRABEV bevacizumab 100 mg/ 4 mL concentrated solution for injection vial

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

November 21, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

Ingredient Name

Bevacizumab

Empowering clinical research with data-driven insights and AI-powered tools.

ZIRABEV bevacizumab 100 mg/ 4 mL concentrated solution for injection vial (309320) - TGA 批准文号 | MedPath